What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey

Michal Shteinberg, Jeanette Boyd, Stefano Aliberti, Eva Polverino, Bridget Harris, Tove Berg, Annette Posthumus, Thomas Ruddy, Pieter Goeminne, Ernie Lloyd, Timothy Alan, Josje Altenburg, Barbara Crossley, Francesco Blasi, James Chalmers

Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020
Journal Issue: January
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Michal Shteinberg, Jeanette Boyd, Stefano Aliberti, Eva Polverino, Bridget Harris, Tove Berg, Annette Posthumus, Thomas Ruddy, Pieter Goeminne, Ernie Lloyd, Timothy Alan, Josje Altenburg, Barbara Crossley, Francesco Blasi, James Chalmers. What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What’s important for people with NTM? An EMBARC-ELF patient survey
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


Nontuberculous mycobacterial disease: an important cause of morbi-mortality in HIV infected subjects
Source: Eur Respir J 2003; 22: Suppl. 45, 333s
Year: 2003

Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey
Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017
Year: 2018



When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019


Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?
Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017
Year: 2017



Patient reported outcomes for non-tuberculous mycobacterial disease
Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019
Year: 2020



The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

When should I suspect NTM disease?
Source: ERS Course 2015
Year: 2015

Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


Aero-environmental bacteriological survey of respiratory non-tuberculosis mycobacterial disease patients
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Looking into real world practice of elder pulmonary non-tuberculous mycobacterial infection.
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Prevalence of non-tuberculous mycobacterial disease among patients evaluated for pulmonary tuberculosis in Iraq 2015-2018
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019

How much do patients and doctors know about extrapulmonary tuberculosis?
Source: Eur Respir J 2005; 26: Suppl. 49, 416s
Year: 2005

Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women
Source: Eur Respir J, 54 (1) 1900252; 10.1183/13993003.00252-2019
Year: 2019



How important is work as a risk for lung infections? A story of tuberculosis and pneumonia
Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working?
Year: 2020


Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021


Pulmonary non-tuberculous mycobacterial infection in patients without predisposing condition, morphological and immunological overview of a french cohort
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases
Source: Eur Respir J 2001; 18: Suppl. 33, 443s
Year: 2001